Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-type voltage-dependent calcium channels, also known as low-voltage-activated (LVA) calcium channels, are critical regulators of cellular excitability and rhythmic firing patterns in the central nervous system and cardiovascular system (Perez-Reyes, 2003, Physiological Reviews). Unlike high-voltage-activated channels, T-type channels (comprising Cav3.1, Cav3.2, and Cav3.3 subtypes) open in response to small depolarizations near the resting membrane potential, allowing them to influence pacemaker activity and signal integration (Iftinca & Zamponi, 2009, Trends in Pharmacological Sciences). They are primarily involved in the pathogenesis of absence epilepsy, where they contribute to the characteristic 3 Hz spike-and-wave discharges, as well as in the transmission of neuropathic pain signals in the spinal cord (Cheong & Shin, 2013, Pflügers Archiv). Therapeutic strategies focus on small-molecule inhibitors, such as ethosuximide and zonisamide, which block the channel pore to dampen neuronal hyperexcitability (Zamponi et al., 2015, Pharmacological Reviews). Beyond neurology, these channels are investigated for their roles in cardiac conduction, hormone secretion, and even cancer cell proliferation, making them versatile targets for drug development (Cribbs, 2006, Circulation Research).
Inhibition of the channel pore to reduce calcium influx during low-voltage depolarization, thereby dampening rhythmic firing and hyperexcitability.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-type voltage-dependent calcium channel (T-type VGCC) (T-type VGCC).